Literature DB >> 22617274

Acute kidney injury.

Rinaldo Bellomo1, John A Kellum, Claudio Ronco.   

Abstract

Acute kidney injury (formerly known as acute renal failure) is a syndrome characterised by the rapid loss of the kidney's excretory function and is typically diagnosed by the accumulation of end products of nitrogen metabolism (urea and creatinine) or decreased urine output, or both. It is the clinical manifestation of several disorders that affect the kidney acutely. Acute kidney injury is common in hospital patients and very common in critically ill patients. In these patients, it is most often secondary to extrarenal events. How such events cause acute kidney injury is controversial. No specific therapies have emerged that can attenuate acute kidney injury or expedite recovery; thus, treatment is supportive. New diagnostic techniques (eg, renal biomarkers) might help with early diagnosis. Patients are given renal replacement therapy if acute kidney injury is severe and biochemical or volume-related, or if uraemic-toxaemia-related complications are of concern. If patients survive their illness and do not have premorbid chronic kidney disease, they typically recover to dialysis independence. However, evidence suggests that patients who have had acute kidney injury are at increased risk of subsequent chronic kidney disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22617274     DOI: 10.1016/S0140-6736(11)61454-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  468 in total

1.  Arginase-2 mediates renal ischemia-reperfusion injury.

Authors:  Wesley M Raup-Konsavage; Ting Gao; Timothy K Cooper; Sidney M Morris; W Brian Reeves; Alaa S Awad
Journal:  Am J Physiol Renal Physiol       Date:  2017-05-17

2.  Predicting Major Adverse Kidney Events among Critically Ill Adults Using the Electronic Health Record.

Authors:  Andrew C McKown; Li Wang; Jonathan P Wanderer; Jesse Ehrenfeld; Todd W Rice; Gordon R Bernard; Matthew W Semler
Journal:  J Med Syst       Date:  2017-08-31       Impact factor: 4.460

Review 3.  Concise Review: Kidney Generation with Human Pluripotent Stem Cells.

Authors:  Ryuji Morizane; Tomoya Miyoshi; Joseph V Bonventre
Journal:  Stem Cells       Date:  2017-09-26       Impact factor: 6.277

Review 4.  Mechanisms of Cisplatin-Induced Acute Kidney Injury: Pathological Mechanisms, Pharmacological Interventions, and Genetic Mitigations.

Authors:  Kristen Renee McSweeney; Laura Kate Gadanec; Tawar Qaradakhi; Benazir Ashiana Ali; Anthony Zulli; Vasso Apostolopoulos
Journal:  Cancers (Basel)       Date:  2021-03-29       Impact factor: 6.639

5.  Resident mesenchymal cells and fibrosis.

Authors:  Nicol Hutchison; Cécile Fligny; Jeremy S Duffield
Journal:  Biochim Biophys Acta       Date:  2012-12-04

6.  Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial.

Authors:  Peter Pickkers; Ravindra L Mehta; Patrick T Murray; Michael Joannidis; Bruce A Molitoris; John A Kellum; Mirjam Bachler; Eric A J Hoste; Oscar Hoiting; Kenneth Krell; Marlies Ostermann; Wim Rozendaal; Miia Valkonen; David Brealey; Albertus Beishuizen; Ferhat Meziani; Raghavan Murugan; Hilde de Geus; Didier Payen; Erik van den Berg; Jacques Arend
Journal:  JAMA       Date:  2018-11-20       Impact factor: 56.272

7.  Loganetin protects against rhabdomyolysis-induced acute kidney injury by modulating the toll-like receptor 4 signalling pathway.

Authors:  Jie Li; Yu-Jun Tan; Ming-Zhi Wang; Ying Sun; Guang-Yan Li; Qi-Long Wang; Jing-Chun Yao; Jiang Yue; Zhong Liu; Gui-Min Zhang; Yu-Shan Ren
Journal:  Br J Pharmacol       Date:  2019-03-27       Impact factor: 8.739

8.  Ferulic Acid Protected from Kidney Ischemia Reperfusion Injury in Mice: Possible Mechanism Through Increasing Adenosine Generation via HIF-1α.

Authors:  Qin Zhou; Xia Gong; Ge Kuang; Rong Jiang; Tianjun Xie; HongTao Tie; XiaHong Chen; Ke Li; JingYuan Wan; Bin Wang
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

9.  The 5-hydroxytryptamine receptor 1F stimulates mitochondrial biogenesis and angiogenesis in endothelial cells.

Authors:  Tess V Dupre; Dorea P Jenkins; Robin C Muise-Helmericks; Rick G Schnellmann
Journal:  Biochem Pharmacol       Date:  2019-09-19       Impact factor: 5.858

10.  Mitogen-Activated Protein Kinase 14 Promotes AKI.

Authors:  Alberto Ortiz; Holger Husi; Laura Gonzalez-Lafuente; Lara Valiño-Rivas; Manuel Fresno; Ana Belen Sanz; William Mullen; Amaya Albalat; Sergio Mezzano; Tonia Vlahou; Harald Mischak; Maria Dolores Sanchez-Niño
Journal:  J Am Soc Nephrol       Date:  2016-09-12       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.